-
公开(公告)号:US20230020272A1
公开(公告)日:2023-01-19
申请号:US17782734
申请日:2020-12-04
申请人: NANEXA AB
发明人: Anders JOHANSSON , Marten ROOTH , Joel HELLRUP
IPC分类号: A61K9/50 , A61K31/706
摘要: There is provided a process for the preparation of composition in the form of a plurality of particles having a weight-, number-, and/or volume-based mean diameter that is between amount 10 nm and about 700 μm, which particles comprise: (a) solid cores, preferably comprising a biologically active agent; and (b) two or more sequentially applied, discrete layers, each of which comprises at least one separately applied coating material, and which two or more layers together surround, enclose and/or encapsulate said cores, which process comprises the sequential steps of: (1) applying an initial layer of at least one coating material to said solid cores by way of a gas phase deposition technique; (2) discharging the coated particles from the gas phase deposition reactor and subjecting the coated particles to agitation to disaggregate particle aggregates formed during step (1) by way of mechanical sieving technique; (3) reintroducing the disaggregated, coated particles from step (2) into the gas phase deposition reactor and applying a further layer of at least one coating material to the reintroduced particles; and (1) optionally repeating steps (2) and (3) one or more times to increase the total thickness of the at least one coating material that enclose(s) said solid core. The gas phase deposition technique is preferably atomic layer deposition. When the cores comprise biologically active agent, the compositions may provide for the delayed or sustained release of said active agent without a burst effect.
-
公开(公告)号:US09629946B2
公开(公告)日:2017-04-25
申请号:US13824398
申请日:2011-09-13
申请人: Anders Johansson , Marten Rooth
发明人: Anders Johansson , Marten Rooth
IPC分类号: A61L31/16 , B29C70/68 , B32B1/02 , B32B27/18 , B32B1/08 , A61L27/34 , A61L27/54 , A61L29/08 , A61L29/16 , B32B25/04 , B32B25/08 , B32B27/08 , B32B27/20 , C08K3/08 , C08K5/00
CPC分类号: A61L31/16 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L2300/104 , A61L2300/404 , A61L2400/12 , A61L2420/04 , B29C70/68 , B32B1/02 , B32B1/08 , B32B25/042 , B32B25/08 , B32B27/08 , B32B27/18 , B32B27/20 , B32B2264/105 , B32B2274/00 , B32B2307/7145 , B32B2535/00 , B32B2581/00 , C08K3/08 , C08K5/0058 , Y10T428/1352 , Y10T428/1372 , Y10T428/1376 , Y10T428/1379 , Y10T428/1386 , Y10T428/139 , Y10T428/1393 , Y10T428/239
摘要: A polymeric product including at least two layers, wherein a functional layer includes a polymeric material and at least one anti-microbial substance, and a protective layer, including a polymeric material arranged outside the functional layer and completely covering the functional layer, wherein the protective layer does not include any anti-microbial substances. A method of producing the product, the use of the same and a kit for producing the product.
-
公开(公告)号:US20130280471A1
公开(公告)日:2013-10-24
申请号:US13824398
申请日:2011-09-13
申请人: Anders Johansson , Marten Rooth
发明人: Anders Johansson , Marten Rooth
IPC分类号: A61L27/54
CPC分类号: A61L31/16 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L2300/104 , A61L2300/404 , A61L2400/12 , A61L2420/04 , B29C70/68 , B32B1/02 , B32B1/08 , B32B25/042 , B32B25/08 , B32B27/08 , B32B27/18 , B32B27/20 , B32B2264/105 , B32B2274/00 , B32B2307/7145 , B32B2535/00 , B32B2581/00 , C08K3/08 , C08K5/0058 , Y10T428/1352 , Y10T428/1372 , Y10T428/1376 , Y10T428/1379 , Y10T428/1386 , Y10T428/139 , Y10T428/1393 , Y10T428/239
摘要: A polymeric product including at least two layers, wherein a functional layer includes a polymeric material and at least one anti-microbial substance, and a protective layer, including a polymeric material arranged outside the functional layer and completely covering the functional layer, wherein the protective layer does not include any anti-microbial substances. A method of producing the product, the use of the same and a kit for producing the product.
摘要翻译: 包括至少两层的聚合物,其中功能层包括聚合物材料和至少一种抗微生物物质,以及保护层,其包括布置在功能层外部并完全覆盖功能层的聚合材料,其中保护层 层不包括任何抗微生物物质。 制造该产品的方法,使用该产品和用于生产该产品的试剂盒。
-
公开(公告)号:US20240261228A1
公开(公告)日:2024-08-08
申请号:US18567466
申请日:2022-06-10
申请人: NANEXA AB
发明人: Anders JOHANSSON , Mårten ROOTH , Erik LINDAHL
IPC分类号: A61K9/50 , A61K31/405 , A61K31/706
CPC分类号: A61K9/5089 , A61K9/501 , A61K31/405 , A61K31/706
摘要: There is provided a process for the preparation of composition in the form of a plurality of particles having a weight-, number-, and/or volume-based mean diameter that is between amount 10 nm and about 700 μm, which particles comprise: (a) solid cores, preferably comprising a biologically active agent; and (b) two or more sequentially applied, discrete layers, each of which comprises at least one separately applied coating material, and which two or more layers together surround, enclose and/or encapsulate said cores, which process comprises the sequential steps of: (1) applying an initial layer of at least one coating material to said solid cores by way of a gas phase deposition technique; (2) subjecting the coated particles to agitation to deagglomerate particle aggregates formed during step (1) by way of a sieving step; (3) applying a further layer of at least one coating material to the deagglomerated particles; and (4) optionally repeating steps (2) and (3) one or more times to increase the total thickness of the at least one coating material that enclose(s) said solid core, wherein at least one of the sieving steps comprises a vibrational sieving technique, in which the vibrational sieving technique comprises supplying electrical power to a vibration motor coupled to a sieve. The gas phase deposition technique is preferably atomic layer deposition. When the cores comprise biologically active agent, the compositions may provide for the delayed or sustained release of said active agent without a burst effect.
-
公开(公告)号:US11214865B2
公开(公告)日:2022-01-04
申请号:US16912599
申请日:2020-06-25
申请人: Nanexa AB
发明人: Anders Johansson , Mårten Rooth , Joel Hellrup
摘要: A reactor for forming fully coated particles having a solid core, the reactor comprises a reactor vessel which is configured to receive particles, and a gas phase coating mechanism that is configured to selectively introduce pulses of gas phase materials that form a coating on the particles. The reactor also includes a sieve (16) that is located within the reactor vessel, and a forcing means that is configured to force the particles through the sieve (16) in use. The sieve is configured to deagglomerate any particle aggregates formed in the reactor vessel upon forcing of the particles by the forcing means through the sieve.
-
公开(公告)号:US20210121415A1
公开(公告)日:2021-04-29
申请号:US17096511
申请日:2020-11-12
申请人: Nanexa AB
摘要: A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.
-
公开(公告)号:US20240277749A1
公开(公告)日:2024-08-22
申请号:US18568219
申请日:2022-06-10
申请人: NANEXA AB
发明人: Anders JOHANSSON , Mårten ROOTH , Erik LINDAHL , Joel HELLRUP , David WESTBERG
IPC分类号: A61K31/706 , A61K9/00 , A61K9/10 , A61K9/50 , A61P35/00 , C23C16/40 , C23C16/455
CPC分类号: A61K31/706 , A61K9/0019 , A61K9/10 , A61K9/501 , A61K9/5073 , A61P35/00 , C23C16/407 , C23C16/45555
摘要: There is provided a pharmaceutical formulation that is useful in the treatment of myelodysplastic syndrome, comprising a plurality of particles suspended in an aqueous carrier system, which particles: (a) have a weight-, number-, or volume-based mean diameter that is between amount 10 nm and about 700 μm; and (b) comprise solid cores comprising azacitidine, or a pharmaceutically-acceptable salt thereof, coated, at least in part, by a coating of inorganic material comprising mixture of: (i) zinc oxide; and (ii) one or more other metal and/or metalloid oxides, wherein the atomic ratio ((i):(ii)) is between at least 1:6 and up to and including about 6:1. Said mixed oxide coated particles are preferably synthesized via a gas phase coating technique, such as atomic layer deposition. The formulation may provide for the delayed or sustained release of azacitidine to treat myelodysplastic syndrome without a burst effect.
-
公开(公告)号:US20230157968A1
公开(公告)日:2023-05-25
申请号:US17919415
申请日:2021-04-16
申请人: NANEXA AB
发明人: Anders JOHANSSON , Mårten ROOTH , Joel HELLRUP
IPC分类号: A61K9/51 , A61K31/706 , A61K9/50
CPC分类号: A61K9/5115 , A61K31/706 , A61K9/5192 , A61K9/501 , A61K9/5089 , A61K9/5123 , A61K9/0019
摘要: There is provided a pharmaceutical or veterinary formulation comprising: (a) a plurality of particles having a weight-, number-, or volume-based mean diameter that is between amount 10 nm and about 700 μm, which particles comprise solid cores coated with zinc oxide; suspended in (b) an oleaginous carrier system comprising a pharmaceutically-acceptable or veterinarily-acceptable oil, which zinc oxide coated particles comprise: (1) solid cores comprising a biologically-active agent; (2) one or more discrete layers surrounding said cores, said one or more layers each comprising at least one separate zinc oxide coating. Said zinc oxide coated particles are preferably synthesized via a gas phase coating technique, such as atomic layer deposition. When the cores comprise biologically-active agent, and the particles are suspended in an oleaginous carrier system, the formulation may provide for the delayed or sustained release of said active agent without a burst effect.
-
公开(公告)号:US20220307132A1
公开(公告)日:2022-09-29
申请号:US17545783
申请日:2021-12-08
申请人: Nanexa AB
发明人: Anders JOHANSSON , Mårten ROOTH , Joel HELLRUP
摘要: A reactor for forming fully coated particles having a solid core, the reactor comprises a reactor vessel which is configured to receive particles, and a gas phase coating mechanism that is configured to selectively introduce pulses of gas phase materials that form a coating on the particles. The reactor also includes a sieve (16) that is located within the reactor vessel, and a forcing means that is configured to force the particles through the sieve (16) in use. The sieve is configured to deagglomerate any particle aggregates formed in the reactor vessel upon forcing of the particles by the forcing means through the sieve.
-
公开(公告)号:US10166198B2
公开(公告)日:2019-01-01
申请号:US15944059
申请日:2018-04-03
申请人: Nanexa AB
摘要: A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.
-
-
-
-
-
-
-
-
-